Filing Flows › Apyx Medical (APYX) › Recalls, complaints & regulation
Apyx Medical (APYX): clinical trials
Apyx Medical (APYX) beyond its filings: 1 active clinical trial.
Apyx Medical's latest quarter
Apyx Medical, Q3 2026: revenue $14.0M (+9% year over year), operating margin -4.1%, net loss $1.8M, operating cash flow −$1.6M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Apyx Medical have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.